Czechia· CZ-0020986
ERMM-1
A 169er-erbium citrat kolloid product containing erbium (169er) citrate, registered in Czechia by CIS bio international, Gif-sur-Yvette Cedex.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ERBIUM (169ER) CITRATE
- Manufacturer
- CIS bio international, Gif-sur-Yvette Cedex
- Country
- Czechia (CZ)
- ATC code
- V10AX04
- ATC class
- 169Er-Erbium citrat Kolloid
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
169er-erbium citrat kolloid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6ae3af5-5afa-4eac-be9c-53052e46df3e GET /v1/drugs/b6ae3af5-5afa-4eac-be9c-53052e46df3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SUS",
"source": "sukl",
"strength": "111MBQ/ML",
"pack_size": "148MBQ",
"substance": "ERBIUM (169ER) CITRATE",
"cz_kod_sukl": "0020986",
"product_type": "RA",
"substance_codes": "16572",
"registration_state": "R",
"registration_number": "88/349/03-C"
}See everything about 169er-erbium citrat kolloid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.